Skip to main content

Cedric Yu, DSc, FAAPM

Academic Title:

Professor Emeritus

Primary Appointment:

Radiation Oncology

Additional Title:

President and CEO of Xcision Medical Systems, LLC

Location:

UMH, GGJ-01

Phone (Primary):

410-328-0324

Fax:

410-328-5279

Education and Training

  • B.Eng., Tianjin University, Tianjin, China, 1982
  • M.Sc., Washington University, St. Louis, MO, 1985
  • Biomedical Engineering Certificate, Washington University, St. Louis, MO, 1988
  • D.Sc., Washington University, St. Louis, MO, 1989

Biosketch

Dr. Yu holds the Carl M. Mansfield, MD, Endowed Professorship in Radiation Oncology in the Department of Radiation Oncology. A scientist/entrepreneur, Dr. Yu has contributed to international recognition of the department’s pioneering developments in radiation treatment technology. He holds more than 20 patents on radiation and related technologies. In 2006 he patented a dedicated breast radiation therapy method, now called the GammaPod system, which was developed with the help of $3.5 million in Small Business Innovation Research grants from the National Institutes of Health. With support from the university’s technical development experts, Dr. Yu founded Xcision Medical Systems, LLC, to pursue production and regulatory approval of this high-precision, noninvasive system for treating breast cancer. He was named the 2010 University of Maryland Baltimore Entrepreneur of the Year. He also serves as a faculty member in the Bioengineering Graduate Program in the School of Engineering at the University of Maryland College Park.

Research/Clinical Keywords

Medical physics, radiation safety, education, technology research and development.

Highlighted Publications

Paganetti H, Yu CX. Photon radiotherapy has reached its limit in terms of catching up dosimetrically with proton therapy. Med Phys. 2016 Aug;43(8):4470. doi: 10.1118/1.4954790. PubMed PMID: 27487862.

Yu CX, Shao X, Zhang J, Regine W, Zheng M, Yu YS, Deng J, Duan Z. GammaPod-a new device dedicated for stereotactic radiotherapy of breast cancer. Med Phys. 2013 May;40(5):051703. doi: 10.1118/1.4798961. PubMed PMID: 23635251; PubMed Central PMCID: PMC3637326.

Mutaf YD, Zhang J, Yu CX, Yi BY, Prado K, D'Souza WD, Regine WF, Feigenberg SJ. Dosimetric and geometric evaluation of a novel stereotactic radiotherapy device for breast cancer: the GammaPod™. Med Phys. 2013 Apr;40(4):041722. doi: 10.1118/1.4794477. PubMed PMID: 23556892.

Betzel GT, Yi BY, Niu Y, Yu CX. Is RapidArc more susceptible to delivery uncertainties than dynamic IMRT? Med Phys. 2012 Oct;39(10):5882-90. doi: 10.1118/1.4749965. PubMed PMID: 23039627; PubMed Central PMCID: PMC3461049.

Yang X, Han-Oh S, Gui M, Niu Y, Yu CX, Yi BY. Four-dimensional dose distributions of step-and-shoot IMRT delivered with real-time tumor tracking for patients with irregular breathing: constant dose rate vs dose rate regulation. Med Phys. 2012 Sep;39(9):5557-66. doi: 10.1118/1.4745562. PubMed PMID: 22957622; PubMed Central PMCID: PMC3436918.

Additional Publication Citations

Awards and Affiliations

×